Lippis Daniel J. 4
4 · Edwards Lifesciences Corp · Filed Jul 28, 2025
Insider Transaction Report
Form 4
Lippis Daniel J.
CVP, TAVR
Transactions
- Sale
Common Stock
2025-07-28$79.46/sh−4,114$326,900→ 22,001.91 total
Footnotes (1)
- [F1]This transaction was executed in multiple trades at prices ranging from $79.4500 to $79.4701. The price reported above reflects the weighted average sale price. The reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.